Prioritization of quality indicators for opioid stewardship

  • Rizk, Elsie Pharm.D
  • Swan, Joshua T. Pharm.D., M.P.H., FCCM
  • Fink, Ezekiel M.D

  • 1 Department of Pharmacy Houston Methodist Houston Methodist Research Institute Houston, TX

    2 Department of Neurology Houston Methodist Hospital Houston, TX

*[email protected]

Disclosures: Drs. Rizk and Swan report that VigiLanz Corporation provided funding for a clinical pharmacy fellow in outcomes research position at Houston Methodist that was used to support this research. Dr. Fink has declared no potential conflicts of interest.

American Journal of Health-System Pharmacy 76(19):p 1458-1459, October 1, 2019. | DOI: 10.1093/ajhp/zxz163
Copyright © Copyright Oxford University Press 2019.
View full text|Download PDF